CancerFax
Dr Rinat Yerushalmi.webp
verifiedCancerFax Verified
schoolMD โ€“ Breast Oncology

Dr.ย Rinatย Yerushalmi

MD, Oncology

Head, Breast Oncology Clinic & Clinical Full Professor

corporate_fareDavidoff Cancer Center, Rabin Medical Center, Israel

check_circleBreast Cancer
check_circleTargeted Therapy & Immunotherapy
check_circleBRCA & HER2+ Disease
check_circleMetastatic Breast Cancer
INSTITUTION
corporate_fareDavidoff Cancer Center, Rabin Medical Center
DEPARTMENT
scienceBreast Oncology Clinic
SPECIALTY
medical_servicesBreast Cancer โ€“ Metastatic, HER2+, BRCA, Triple-Negative
LOCATION
location_onPetah Tikva, Israel
INTERNATIONAL PATIENTS
publicInternational Patients Welcome
person

Rinat Yerushalmi

MD, Oncology

Prof. Rinat Yerushalmi is a senior Israeli breast cancer oncologist and Head of the Breast Oncology Clinic at the Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel. She is also a Clinical Full Professor in Oncology at the Faculty of Medicine, Tel Aviv University, with a research record spanning three decades.

Prof. Yerushalmi's clinical and academic work is dedicated to breast cancer across the full spectrum of the disease, including early breast cancer, metastatic breast cancer, HER2-positive disease, hormone receptor-positive disease, triple-negative breast cancer, and BRCA1/2 mutation-associated breast cancer. Her treatment approach is grounded in biomarker-guided personalised medicine, incorporating chemotherapy, endocrine therapy, anti-HER2 therapy, targeted therapy, and immunotherapy where appropriate. She heads the Breast Cancer Research Laboratory at the Felsenstein Medical Research Center, where research focuses on tumour microenvironment biology, drug resistance mechanisms, and translational immunotherapy in triple-negative breast cancer. Tel Aviv University lists 196 peer-reviewed research outputs under her academic profile, making her one of Israel's most published breast oncologists. Patients referred through CancerFax may seek Prof. Yerushalmi for complex breast cancer review, second opinions, and advanced systemic therapy planning.

calendar_month
M
Visiting Days
public
International Patient Coordination

CancerFax can coordinate medical-report review and consultation support for international patients seeking expert breast cancer opinion from Prof. Yerushalmi at Rabin Medical Center.

stars

Why Consider Prof. Rinat Yerushalmi?

Prof. Yerushalmi brings together clinical leadership, deep research expertise, and a multidisciplinary environment at one of Israel's leading cancer centres โ€” making her especially relevant for patients with complex, advanced, or rare breast cancer presentations.

local_hospital
Head of Breast Oncology at Davidoff Cancer Center
Prof. Yerushalmi leads the Breast Oncology Clinic at the Davidoff Cancer Center, Rabin Medical Center โ€” one of Israel's major comprehensive cancer treatment and research hubs, providing integrated breast cancer care from diagnosis through follow-up.
science
Subspecialty Depth Across All Breast Cancer Subtypes
Her clinical focus covers early and metastatic breast cancer, HER2-positive disease, HR-positive / HER2-negative disease, triple-negative breast cancer, BRCA1/2-associated breast cancer, and CNS metastases โ€” giving her particular relevance for molecularly complex or advanced cases.
biotech
Active Translational Research Programme
As Head of the Breast Cancer Research Laboratory at the Felsenstein Medical Research Center, Prof. Yerushalmi works on immunotherapy mechanisms, biomarkers, targeted therapy, and drug resistance in breast cancer. Her academic record includes 196 peer-reviewed research outputs at Tel Aviv University.
language
International Consultation Support via CancerFax
CancerFax can help international patients prepare and submit medical records for review, coordinate second-opinion requests, and facilitate communication with the Rabin Medical Center team, subject to hospital availability and case acceptance.
verified_user

Areas of Specialisation

Comprehensive breast cancer care โ€” from early-stage through advanced and metastatic disease

Prof. Yerushalmi's practice is focused entirely on breast cancer, spanning the full range of disease subtypes and treatment modalities. Her clinical and laboratory work are closely aligned, enabling evidence-informed treatment planning for complex cases.

Breast Cancer Specialties

Metastatic & Advanced Breast Cancer

Management of systemic breast cancer, including CNS metastases, with biomarker-driven and personalised treatment strategies.

starsHER2-Positive Metastatic Breast Cancer
  • arrow_rightAnti-HER2 therapy including first- and second-line systemic treatment planning
  • arrow_rightManagement of HER2-positive disease with CNS involvement
  • arrow_rightIntegration of novel HER2-directed agents where clinically indicated
starsHR-Positive / HER2-Negative Metastatic Breast Cancer
  • arrow_rightEndocrine therapy sequencing and CDK4/6 inhibitor strategies
  • arrow_rightRecurrence risk assessment and personalised systemic treatment planning
starsTriple-Negative Breast Cancer
  • arrow_rightChemotherapy protocols for TNBC including neoadjuvant and metastatic settings
  • arrow_rightImmunotherapy for eligible triple-negative breast cancer patients
  • arrow_rightTranslational research on tumour microenvironment and drug resistance

BRCA-Associated & Hereditary Breast Cancer

Specialist management of breast cancer in patients with BRCA1/2 pathogenic variants, including treatment selection and risk counselling.

starsBRCA1/2 Mutation-Associated Breast Cancer
  • arrow_rightTreatment planning for BRCA carriers across disease stages
  • arrow_rightPARP inhibitor eligibility assessment where applicable
  • arrow_rightCNS metastatic patterns and outcomes in BRCA-related breast cancer

Early Breast Cancer & Personalised Medicine

Evidence-based management of early-stage breast cancer with a focus on biomarker-guided treatment decisions and recurrence risk reduction.

starsEarly Breast Cancer Systemic Therapy
  • arrow_rightNeoadjuvant and adjuvant chemotherapy, endocrine therapy, and targeted treatment
  • arrow_rightOncotype DX recurrence score-informed chemotherapy decisions
  • arrow_rightPersonalised medicine based on tumour biology and molecular profiling
Clinical Focus Areas
check_circleMetastatic Breast Cancer
check_circleHER2-Positive Breast Cancer
check_circleTriple-Negative Breast Cancer
check_circleBRCA1/2-Associated Breast Cancer
check_circleHR-Positive / HER2-Negative Breast Cancer
check_circleEarly Breast Cancer & Recurrence Risk
medical_services

Procedures & Clinical Services

Systemic treatment planning, biomarker-guided care, and multidisciplinary breast oncology

Prof. Yerushalmi provides comprehensive medical oncology services for breast cancer patients, with an emphasis on evidence-based systemic therapy, molecular diagnostics, and research-informed personalised care.

Systemic Cancer Treatment Planning

Medical Oncology

Chemotherapy, endocrine therapy, and targeted systemic treatment for early and advanced breast cancer across all molecular subtypes.

Treatment Options
arrow_rightChemotherapy protocols for early-stage, neoadjuvant, adjuvant, and metastatic settings
arrow_rightEndocrine therapy for hormone receptor-positive disease
arrow_rightAnti-HER2 therapy for HER2-positive breast cancer

Targeted & Immunotherapy

Targeted Therapy

Biomarker-guided targeted agents and immunotherapy for eligible breast cancer patients, informed by molecular profiling and clinical research.

Targeted & Immune Approaches
arrow_rightCDK4/6 inhibitors for HR-positive / HER2-negative metastatic disease
arrow_rightPARP inhibitors for BRCA-associated breast cancer where indicated
arrow_rightImmunotherapy for eligible triple-negative breast cancer patients
arrow_rightBiomarker and molecular profiling to guide treatment selection

Diagnostic & Multidisciplinary Review

Multidisciplinary

Integrated diagnosis and multidisciplinary breast cancer management at the Davidoff Cancer Center, including pathology review, imaging correlation, and tumour board involvement.

Diagnostic Services
arrow_rightTumour board review and multidisciplinary treatment planning
arrow_rightMolecular and pathology-based staging and diagnosis
arrow_rightRecurrence risk assessment using validated tools such as Oncotype DX

Second Opinion for Breast Cancer

Second Opinion

Expert second-opinion review for patients with complex, recurrent, advanced, or rare breast cancer presentations, including cases with BRCA mutations, CNS involvement, or prior treatment failure.

Second Opinion Scope
arrow_rightReview of pathology, imaging, and prior treatment history
arrow_rightIndependent systemic treatment recommendation
arrow_rightCoordination through CancerFax for international patients
menu_book

Research & Publications

Peer-reviewed contributions in breast cancer biology, treatment, and translational research

Prof. Yerushalmi has an extensive academic record in breast cancer research. Tel Aviv University lists 196 research outputs under her profile, including 172 original articles, 12 review articles, book chapters, and editorial contributions. She leads the Breast Cancer Research Laboratory at the Felsenstein Medical Research Center.

Selected Peer-Reviewed Publications
arrow_rightMetastatic behavior of breast cancer subtypes โ€“ study on subtype-specific metastatic patterns and post-relapse survival (PubMed indexed)
arrow_rightCentral nervous system metastases in breast cancer patients with BRCA1/2 pathogenic variants โ€“ CNS metastatic patterns and outcomes in BRCA-related disease (PubMed, 2024)
arrow_rightBRCA1/2 mutation carriers vs the general breast cancer population โ€“ comparative outcomes study, Davidoff Cancer Center / Tel Aviv University affiliation (Springer)
arrow_rightSecond-line treatment of HER2-positive metastatic breast cancer โ€“ systemic therapy outcomes, Davidoff Cancer Center affiliation (PubMed indexed)
arrow_rightChemotherapy for oestrogen-receptor-negative breast cancer โ€“ Lancet commentary co-authored with Karen Gelmon (PubMed indexed)
Translational Research โ€“ Felsenstein Medical Research Center
arrow_rightTriple-negative breast cancer โ€“ immunotherapy mechanisms, tumour microenvironment, and drug resistance
arrow_rightBiomarkers in breast cancer โ€“ GRP78, CD45, Gal3BP/Galectin-3, and chemotherapy response markers
arrow_rightTargeted therapy and drug resistance mechanisms in breast cancer subtypes
arrow_rightImmunotherapy translational research including checkpoint pathways in TNBC
Research Profile

A full publication list is available via Tel Aviv University CRIS and PubMed under Rinat Yerushalmi Misheli. ORCID: 0000-0001-6221-2859.

school

Education & Training

Prof. Yerushalmi completed her medical education at the Technion Israel Institute of Technology and her oncology residency at Beilinson Hospital, Rabin Medical Center. She subsequently undertook a multi-year advanced oncology fellowship at Vancouver Cancer Hospital, British Columbia, Canada, before returning to Rabin Medical Center where she has built her clinical and academic career.

Undergraduate & Medical Training
MD
Technion Israel Institute of Technology, Ruth and Bruce Rappaport Faculty of Medicine
Year not publicly confirmed
Oncology Residency
Oncology Residency Training
Beilinson Hospital, Rabin Medical Center, Israel
Year not publicly confirmed
Advanced Fellowship
Advanced Oncology Fellowship (3 years)
Vancouver Cancer Hospital, British Columbia, Canada
Duration: 3 years (exact dates not publicly confirmed)
Academic Appointment
Clinical Full Professor, Oncology
Faculty of Medicine, Tel Aviv University
Academic record from 1996 โ€“ present
work_history

Clinical Experience

Prof. Yerushalmi's career has been centred at the Davidoff Cancer Center, Rabin Medical Center, where she holds the position of Head of the Breast Oncology Clinic and leads the Breast Cancer Research Laboratory at the Felsenstein Medical Research Center. In parallel, she holds a Clinical Full Professorship at Tel Aviv University's Faculty of Medicine.

Head, Breast Oncology Clinic / Breast Cancer Unit
Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center
Faculty of Medicine, Tel Aviv University
check_circleClinical leadership of the Breast Oncology Clinic at Davidoff Cancer Center
check_circleHead, Breast Cancer Research Laboratory, Felsenstein Medical Research Center
check_circleClinical Full Professor in Oncology, Tel Aviv University
check_circleAdvanced fellowship training at Vancouver Cancer Hospital, Canada
check_circleMultidisciplinary breast cancer care and tumour board participation
check_circleActive clinical research programme with 196+ peer-reviewed outputs
language

Languages & International

Prof. Yerushalmi consults in the following verified languages. CancerFax can coordinate professional medical interpreter support for patients who require assistance in other languages.

๐Ÿ‡ฌ๐Ÿ‡งEnglish
๐Ÿ‡ฎ๐Ÿ‡ฑHebrew
Interpreter Support Available

CancerFax can coordinate professional medical interpreter support for international patients consulting with Prof. Yerushalmi.

CancerFax can arrange professional medical interpreter support where required.

support_agentHow CancerFax Helps

How CancerFax Helps You Access Dr. Rinat Yerushalmi

CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Rinat Yerushalmi's team โ€” with full coordination from initial inquiry to consultation.

description

Medical Report Review

Free review of your pathology results, imaging, molecular profiling, and treatment history โ€” prepared as a structured clinical summary for Dr. Rinat Yerushalmi's team.

medical_services

Treatment Eligibility Screening

CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Rinat Yerushalmi before you travel, so you arrive with a clear pathway.

send

Case Submission

We coordinate direct case submission to Dr. Rinat Yerushalmi's department, including all documentation required for clinical review and appointment scheduling.

calendar_month

Appointment & Consultation Coordination

CancerFax manages appointment scheduling with Dr. Rinat Yerushalmi's team, confirming availability and aligning timelines with your travel plans.

flight_takeoff

Travel, Visa & Logistics Support

We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.

support_agent

Follow-Up & Continuity of Care

After your consultation or treatment, CancerFax facilitates communication between Dr. Rinat Yerushalmi's team and your home oncologist for seamless post-treatment follow-up.

quiz

Frequently Asked Questions About Prof. Rinat Yerushalmi

Prof. Rinat Yerushalmi specialises exclusively in breast cancer. Her clinical focus covers early breast cancer, metastatic breast cancer, HER2-positive breast cancer, hormone receptor-positive disease, triple-negative breast cancer, and BRCA1/2 mutation-associated breast cancer, including cases with CNS metastases.

Prof. Yerushalmi is based at the Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, in Petah Tikva, Israel. She heads the Breast Oncology Clinic and the Breast Cancer Research Laboratory at the Felsenstein Medical Research Center within the same institution.

CancerFax can coordinate medical-report review and consultation support for international patients seeking an expert breast cancer opinion from Prof. Yerushalmi at Rabin Medical Center. Access is subject to hospital availability and case acceptance. Submit your reports through CancerFax to initiate the process.

Yes. A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, treatment history, and relevant test results. Prof. Yerushalmi has particular experience in complex presentations including advanced, recurrent, BRCA-associated, and triple-negative breast cancer. The consultation format and availability depend on the hospital's scheduling.

Yes. BRCA1/2 mutation-associated breast cancer is a major area of both her clinical practice and published research. Her work includes studies on CNS metastatic patterns in BRCA carriers and comparative outcomes between BRCA mutation carriers and the general breast cancer population.

Submit your medical reports through CancerFax using the Send Your Reports option. The CancerFax team will review the documents, prepare the case for submission, and coordinate the next steps with the Davidoff Cancer Center team, subject to availability and case eligibility.

sendGet Expert Oncology Guidance

Connect with Rinat Yerushalmi Today

Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.

Free case review ยท No commitment ยท Response within 24 hours ยท Available in 12+ languages

Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.

upload_fileUpload ReportschatWhatsApp